Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae

Nitric oxide (NO) has been associated with protection against various parasitic and viral infections and may play a similar role in bacterial infections, We studied the role of NO in host defense against Klebsiella pneumoniae infection in the lung. Initial studies demonstrated a time-dependent increase in NO production of the lungs of CBA/J mice following the intratracheal administration of K. pneumoniae (7 x 10(2) CFU). To assess the role of NO in Klebsiella pneumonia, mice were treated intraperitoneally with either L-NAME (N-omega-nitro-L-arginine methylester), a competitive inhibitor of NO synthesis, or D-NAME, an inert enantiomer. The treatment of klebsiella-infected mice with L-NAME resulted in a 10- and 46-fold increase in K. pneumoniae CFU in lungs and blood, respectively, at 48 h post-K. pneumoniae inoculation compared to treatment of mice with D-NAME. In addition, a greater-than-twofold increase in mortality was evident in L-NAME-treated mice compared to the mortality in control animals, No significant difference in bronchoalveolar lavage inflammatory cell profiles was noted between L-NAME- and D-NAME-treated mice with Klebsiella pneumonia, Interestingly, increased levels of tumor necrosis factor, gamma interferon, macrophage inflammatory protein 1 alpha (MIP-1 alpha), and MIP-2 mRNA and protein were noted in infected mice treated with L-NAME compared to the levels in mice treated with D-NAME. Importantly, the in vitro incubation of murine alveolar macrophages with L-NAME, but not dth D-NAME, resulted in a significant impairment in both the phagocytosis and killing of K. pneumoniae, In total, these results suggest that NO plays a critical role in antibacterial host defense against K. pneumoniae,in part by regulating macrophage phagocytic and microbicidal activity.